E-LIB Suche - Ergebnisse für: Mross, K.

1

Population Modeling Integrating Pharmacokinetics, Pharmacod..:

Diekstra, MH ; Fritsch, A ; Kanefendt, F...
CPT: Pharmacometrics & Systems Pharmacology. 6 (2017) 9 - p. 604-613 , 2017

Link: https://doi.org/10.1002/..

2

Phase I Study of the Plk1 Inhibitor BI 2536 Administered In..:

Frost, A. ; Mross, K. ; Steinbild, S....
Current Oncology. 19 (2012) 1 - p. 28-35 , 2012

Link: https://doi.org/10.3747/..

3

Phase II study of nimotuzumab, a humanized monoclonal anti-..:

Strumberg, Dirk ; Schultheis, Beate ; Scheulen, M. E....
Investigational New Drugs. 30 (2010) 3 - p. 1138-1143 , 2010

Link: https://doi.org/10.1007/..

4

496 A phase I dose-escalation study of BI 811283, an Aurora..:

Scheulen, M. ; Mross, K. ; Richly, H....
European Journal of Cancer Supplements. 8 (2010) 7 - p. 158-159 , 2010

Link: https://doi.org/10.1016/..

5

Variants in the SLCO1B3 Gene: Interethnic Distribution and ..:

Smith, N F ; Marsh, S ; Scott-Horton, T J...
Clinical Pharmacology & Therapeutics. 81 (2007) 1 - p. 76-82 , 2007

Link: https://doi.org/10.1038/..

6

Results from an in vitro and a clinical/pharmacological pha..:

Mross, K. ; Steinbild, S. ; Baas, F....
European Journal of Cancer. 43 (2007) 1 - p. 55-63 , 2007

Link: https://doi.org/10.1016/..

7

41 POSTER Clinical and biomarker responses in a phase I stu..:

Strumberg, D. ; Christensen, O. ; Strecker, R....
European Journal of Cancer Supplements. 4 (2006) 12 - p. 17 , 2006

Link: https://doi.org/10.1016/..

8

73 POSTER Pharmacokinetic characterization of BIBF 1120, an..:

Stopfer, P. ; Roth, W. ; Mross, K....
European Journal of Cancer Supplements. 4 (2006) 12 - p. 26 , 2006

Link: https://doi.org/10.1016/..

9

401 POSTER Pharmacokinetic characterization of BI 2536 - a ..:

Trommeshauser, D. ; Mross, K. ; Steinbild, S....
European Journal of Cancer Supplements. 4 (2006) 12 - p. 123 , 2006

Link: https://doi.org/10.1016/..

10

135 A clinical phase I dose escalation, pharmacokinetic (PK..:

Mross, K. ; Baas, F. ; Medinger, M....
European Journal of Cancer Supplements. 2 (2004) 8 - p. 44 , 2004

Link: https://doi.org/10.1016/..

11

557 BBR 3576: phase I dose escalation study in patients wit..:

Scheulen, M.E. ; Mross, K. ; Peschel, Ch....
European Journal of Cancer Supplements. 1 (2003) 5 - p. S168-S169 , 2003

Link: https://doi.org/10.1016/..

12

542 A multicenter, randomized phase III study on neurotoxic..:

Mielke, S. ; Mross, K. ; Gerds, T.A....
European Journal of Cancer Supplements. 1 (2003) 5 - p. S164 , 2003

Link: https://doi.org/10.1016/..

13

Altered clearance of unbound paclitaxel in elderly patients..:

Smorenburg, C.H ; ten Tije, A.J ; Verweij, J...
European Journal of Cancer. 39 (2003) 2 - p. 196-202 , 2003

Link: https://doi.org/10.1016/..

14

Phase II Study of Combined 5-Fluorouracil/Ginkgo biloba Ext..:

Hauns, B. ; H�ring, B. ; K�hler, S...
Phytotherapy Research. 15 (2001) 1 - p. 34-38 , 2001

Link: https://doi.org/10.1002/..

15

Effekte einer adjuvanten Misteltherapie bei operierten Pati..:

Mross, K.
Strahlentherapie und Onkologie. 177 (2001) 9 - p. 495-496 , 2001

Link: https://doi.org/10.1007/..